APA-referens (7:e uppl.)

Seneviratne, S. O., Marriott, M., Ramanathan, S., Yeh, W., Brilot-Turville, F., Butzkueven, H., & Monif, M. (2022). Failure of alemtuzumab therapy in three patients with MOG antibody associated disease. BMC Neurology, 22(1), . https://doi.org/10.1186/s12883-022-02612-6

Chicago-referens (17:e uppl.)

Seneviratne, Sinali O., Mark Marriott, Sudarshini Ramanathan, Wei Yeh, Fabienne Brilot-Turville, Helmut Butzkueven, och Mastura Monif. "Failure of Alemtuzumab Therapy in Three Patients with MOG Antibody Associated Disease." BMC Neurology 22, no. 1 (2022). https://doi.org/10.1186/s12883-022-02612-6.

MLA-referens (9:e uppl.)

Seneviratne, Sinali O., et al. "Failure of Alemtuzumab Therapy in Three Patients with MOG Antibody Associated Disease." BMC Neurology, vol. 22, no. 1, 2022, https://doi.org/10.1186/s12883-022-02612-6.

Varning: dessa hänvisningar är inte alltid fullständigt riktiga.